WO2009095646A3 - Peptides from factor viii - Google Patents
Peptides from factor viii Download PDFInfo
- Publication number
- WO2009095646A3 WO2009095646A3 PCT/GB2009/000187 GB2009000187W WO2009095646A3 WO 2009095646 A3 WO2009095646 A3 WO 2009095646A3 GB 2009000187 W GB2009000187 W GB 2009000187W WO 2009095646 A3 WO2009095646 A3 WO 2009095646A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptides
- factor viii
- haemophilia
- inhibitors
- patients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to compositions comprising peptides for preventing or treating the development of inhibitors in patients with haemophilia, in particular certain peptides and / or peptide fragments derived from factor VIII.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0801513.3A GB0801513D0 (en) | 2008-01-28 | 2008-01-28 | Peptides from factor VIII |
GB0801513.3 | 2008-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009095646A2 WO2009095646A2 (en) | 2009-08-06 |
WO2009095646A3 true WO2009095646A3 (en) | 2010-03-11 |
Family
ID=39186435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2009/000187 WO2009095646A2 (en) | 2008-01-28 | 2009-01-23 | Peptides from factor viii |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0801513D0 (en) |
WO (1) | WO2009095646A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102458445A (en) * | 2009-05-18 | 2012-05-16 | 艾匹托普技术(布里斯托尔)有限公司 | Peptide |
CN103298482A (en) * | 2010-10-27 | 2013-09-11 | 巴克斯特国际公司 | FVIII peptides for immune tolerance induction and immunodiagnostics |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2917232T (en) * | 2012-11-12 | 2017-06-09 | Apitope Int Nv | Factor viii-derived peptides for use in the treatment of haemophilia a |
MX2016005333A (en) | 2013-10-22 | 2017-02-15 | Dbv Tech | Method of treating haemophilia by inducing tolerance to blood factors. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002060917A2 (en) * | 2000-12-01 | 2002-08-08 | Regents Of The University Of Minnesota | Method to treat hemophilia |
WO2002090542A2 (en) * | 2001-05-09 | 2002-11-14 | Departement Central De Fractionnement De La Croix-Rouge S.C.R.L. | Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
WO2003087161A1 (en) * | 2002-04-18 | 2003-10-23 | Merck Patent Gmbh | Modified factor viii |
WO2009071886A1 (en) * | 2007-12-04 | 2009-06-11 | Apitope Technology (Bristol) Limited | Fviii peptides and their use in tolerising haemophiliacs |
-
2008
- 2008-01-28 GB GBGB0801513.3A patent/GB0801513D0/en not_active Ceased
-
2009
- 2009-01-23 WO PCT/GB2009/000187 patent/WO2009095646A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002060917A2 (en) * | 2000-12-01 | 2002-08-08 | Regents Of The University Of Minnesota | Method to treat hemophilia |
WO2002090542A2 (en) * | 2001-05-09 | 2002-11-14 | Departement Central De Fractionnement De La Croix-Rouge S.C.R.L. | Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
WO2003087161A1 (en) * | 2002-04-18 | 2003-10-23 | Merck Patent Gmbh | Modified factor viii |
WO2009071886A1 (en) * | 2007-12-04 | 2009-06-11 | Apitope Technology (Bristol) Limited | Fviii peptides and their use in tolerising haemophiliacs |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102458445A (en) * | 2009-05-18 | 2012-05-16 | 艾匹托普技术(布里斯托尔)有限公司 | Peptide |
CN102458445B (en) * | 2009-05-18 | 2014-06-11 | 艾匹托普国际股份有限公司 | Peptide |
CN103298482A (en) * | 2010-10-27 | 2013-09-11 | 巴克斯特国际公司 | FVIII peptides for immune tolerance induction and immunodiagnostics |
CN103298482B (en) * | 2010-10-27 | 2015-08-19 | 巴克斯特国际公司 | For immunologic tolerance induction and the FVIII peptide of immunologic diagnosis |
Also Published As
Publication number | Publication date |
---|---|
WO2009095646A2 (en) | 2009-08-06 |
GB0801513D0 (en) | 2008-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010034032A3 (en) | Methods for preparing purified polypeptide compositions | |
WO2007075439A3 (en) | Compositions and methods for treating obesity and related metabolic disorders | |
DE602008002693D1 (en) | VACCINE PEPTIDE COMBINATIONS AGAINST CATERING ALLERGY | |
WO2008060374A3 (en) | Methods and compositions useful for diabetic wound healing | |
WO2009094172A3 (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
ZA201001054B (en) | Peptide with reduced dimer formation | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2009149339A3 (en) | P53 activator peptides | |
MX350046B (en) | Treatments for gastrointestinal disorders. | |
NZ607892A (en) | Tfpi inhibitors and methods of use | |
WO2012014214A3 (en) | Peptides derived from plasminogen activator inhibitor-1 (pai-1) for the treatment of hypertension | |
WO2011017132A3 (en) | Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration | |
WO2008093058A3 (en) | Peptides and their use | |
WO2009120380A3 (en) | Recombinant rhinovirus vectors | |
WO2009114461A3 (en) | Angiotensin (1-7) dosage forms and uses thereof | |
WO2011098778A3 (en) | Peptides for vaccines against birch allergy | |
WO2009009034A3 (en) | Methods and compositions useful in the treatment of mucositis | |
MX2011008179A (en) | Peptides for vaccine. | |
WO2009047513A3 (en) | Antagonists of kisspeptin and uses thereof | |
WO2009095646A3 (en) | Peptides from factor viii | |
WO2009138494A3 (en) | Amino acid sequences directed against toll-like receptors and their use for the treatment of diseases related to toll-like receptors | |
IL213026A0 (en) | TNA-a INHIBITING PEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | |
WO2013192238A3 (en) | Compositions and methods for treatment of diabetes | |
WO2012090207A3 (en) | Par1 and par2 c-tail peptides and peptide mimetics | |
WO2008014603A3 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09705078 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09705078 Country of ref document: EP Kind code of ref document: A2 |